Sort   by:  
 Page size 
MetabolomicsTranscriptomic and Metabolomics Profiling of Phage–Host Interactions between Phage PaP1 and Pseudomonas aeruginosa
The basic biology of bacteriophage–host interactions has attracted increasing attention due to a renewed interest in the therapeutic potential of bacteriophages. In addition, knowledge of the host pathways inhibited by phage may provide clues to novel drug targets. However, the effect of phage on ba...
2018-05-03 | MTBLS431 | MetaboLights
ProteomicsRational in vitro design of a two-phage cocktail against a contemporary Acinetobacter baumannii strain recovered from a burned patient at CHUV
Acinetobacter baumannii is currently a major threat to human health. With the spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, the development of complementary strategies is needed. A promising complimentary and realistic strategy could be phage therapy, which uses b...
ORGANISM(S): Acinetobacter baumannii (strain ATCC 17978 / CIP 53.77 / LMG 1025 / NCDC KC755 / 5377) 
2025-12-08 | PXD062593 | Pride
A. baumannii Phage cocktail Phage therapy 
GenomicsPhage therapy targeted E.coli
Phage therapy targeted E.coli Raw sequence reads
PRJNA1158932 | ENA
UnknownCompassionate Use of Bacteriophages for Failed Persistent Infections During the First 5 Years of the Israeli Phage Therapy Center.
Not available
S-EPMC10205549 | biostudies-literature
GenomicsCase study- Neonatal infection & AMR & phage therapy
Case study- Neonatal infection & AMR & phage therapy
PRJEB80910 | ENA
UnknownPhage Therapy Experience at the Eliava Phage Therapy Center: Three Cases of Bacterial Persistence.
Not available
S-EPMC8540005 | biostudies-literature
ProteomicsEnhancing phage therapy by coating single bacteriophage-infected bacteria with polymer to preserve phage vitality
The efficacy of bacteriophages in treating bacterial infections largely depends on the phages’ vitality, which is impaired when they are naturally released from their hosts, as well as by culture media, manufacturing processes and other insults. Here, by wrapping phage-invaded bacteria individually ...
ORGANISM(S): Salmonella phage SFP10 
2025-02-05 | PXD054755 | Pride
Bacteriophage single-cell-nanocoating phage therapy 
ProteomicsThe component parts of bacteriophage virions accurately defined by a new machine-learning approach built on evolutionary features.
Klebsiella pneumoniae has risen to prominence as a major threat to human health, with hypervirulent and drug-resistant lineages spreading globally. Given their antimicrobial resistant phenotypes, new therapies are required for the treatment of these infections, and bacteriophages (phages) that kill ...
ORGANISM(S): Klebsiella phage ST405-OXA48phi1.1 
2021-04-30 | PXD020607 | Pride
Phage Prediction Machine learning 
UnknownA Thorough Synthesis of Phage Therapy Unit Activity in Poland-Its History, Milestones and International Recognition.
Not available
S-EPMC9227841 | biostudies-literature
UnknownPhage Therapy in a 16-Year-Old Boy with Netherton Syndrome.
Not available
S-EPMC5494523 | biostudies-literature
Sort   by:  
 Page size